PPT-Thalidomide-based Regimens:

Rates of VTE in Newly Diagnosed MM Treatment No Prophylaxis Any Prophylaxis ASA Warfarin 1125 mgd Prophylactic LMWH Therapeutic Anticoagulation T alone 95 CI 13 0427 . KGMU. Top five states in India which have highest number of leprosy cases. State 2009-10 2010-11 2011-12 2012-13. Uttar Pradesh 27,473 25,509 24,627 24,222. Health. , . Law. . and. . Bioethics. . 2014. By. : Ana Granadeiro. 1. background . The . release of thalidomide in the 1950s and 1960s led to the world’s most . publicised. pharmaceutical disaster.. Thalidomide was found to be unsafe for pregnant women as it affected their developing foetuses. Many women who took the drug gave birth to babies with severe limb deformities. . Later on Doctors discovered thalidomide could cure leprosy and started for patient suffering with the disease in the developing world. But again children were born with abnormalities.. DATA SHEET THALOMID Teratogenic effects: Thalidomide has caused severe birth defects when taken during pregnancy. Thalidomide should never be used by women who are pregnant or who could become pregn Rates of VTE* in Newly Diagnosed MM . Treatment. No Prophylaxis. Any Prophylaxis. ASA. Warfarin. 1-1.25 mg/d. Prophylactic LMWH. Therapeutic Anticoagulation. T alone . (95% CI) . 1.3 . (0.4–2.7) . KGMU. Top five states in India which have highest number of leprosy cases. State 2009-10 2010-11 2011-12 2012-13. Uttar Pradesh 27,473 25,509 24,627 24,222. Pierpaolo Andriani. Kedge Business School, France. Email: pier2paolo@gmail.com. Part of this work has been done in collaboration with Mariano Mastrogiorgio and . Ayfer. Ali. Definition . “We suggest that such characters, evolved for other usages (or for no function at all), and later “coopted” for their current role, be called . Learning Objectives. Understand when to switch to a second-line regimen. Know preferred second-line regimens for adults (including pregnant and breastfeeding women), adolescents, and children. Describe common drug resistance mutations and how they influence choosing a second-line regimen. Dr. . M.V.Raghavendra. . Rao. ,. Professor of Medical . Microbiology, Immunology and . Parasitology,. Dean (Students Affairs). Avalon University School of Medicine. Sta. . Rosaweg. 122-124. Willemstad, . This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. Anastasiya Nestsiarovich, MD, PhD. Postdoctoral Fellow. University of New . Mexico Health Sciences Center. Department of Internal . Medicine. Center . for Global . Health. September 16, 2019. Research team:. unexpected and serious damage.  to unborn babies in the 1950s and 1960s. Thalidomide was developed as a sleeping pill, but it was also thought to be useful for easing morning sickness in pregnant women. Unfortunately, it had not been tested for use in this way.. and . Virologic. Outcomes . for Treatment-experienced . People Living with HIV Switching to MTR or STR ART since 2018 . Ben Chastek. 1. , Amy Anderson. 1. , Joshua Gruber. 2. , Sunil Majethia. 2. , Woodie Zachry. R. egimens . m. ay Need . O. ptimization for Youth Failing ART. V Kouamou. , J Manasa, D Katzenstein, A McGregor, CE Ndhlovu, A T Makadzange, PESU Study Team. C. onflict . of . Interest . D. eclaration.